Prevalence of Thyroid Dysfunction Among Type-2 Diabetes Patients in an Urban Diabetes Hospital, Bangladesh
[1]
Fauzia Moslem, Department of Radiology and Imaging, Bangladesh Institute of Health Science Hospital, Dhaka, Bangladesh.
[2]
Tapasi Sarker Bithi, Department of Radiology and Imaging, Bangladesh Institute of Health Science Hospital, Dhaka, Bangladesh.
[3]
Animesh Biswas, Department of Public Health Sciences, Örebro University, Örebro, Sweden; Reproductive and Child Health Unit, Centre for Injury Prevention and Research (CIPRB), Dhaka, Bangladesh.
Introduction: Diabetes Mellitus (DM) is one of the leading endocrine disorders worldwide. Bangladesh has shown diabetes as a silent killer in adults. There is an established association between diabetes and thyroid disorder. The prevalence of thyroid disorders among diabetes patients is still not known. Objectives: To explore the prevalence of thyroid dysfunction among type-2 diabetes patients attending a specialist diabetes centre in urban Dhaka. Methods: A cross sectional study was performed. Two hundred and thirty two patients with type-2 diabetes mellitus came to the specialized diabetes centre between March and August 2014 and were enrolled for the study. All patients underwent a thyroid clinical and laboratory examination. Results: Prevalence rate of thyroid dysfunction was 10%. Females were found with higher rate of thyroid dysfunction (78.3%) with male (21.7%). The majority of the patients had diabetes for more than a five-year duration (52%). Patients aged between 41-50 years were found to be more affected with thyroid dysfunction (34.8%). Conclusions: The prevalence of thyroid disorder among female diabetes patients were higher. All patients had hypothyroidism. The approach of using a screen test to explore thyroid disorders was not effective, rather routine screening is recommended for all type 2 diabetes patients to reduce the burden of the disease.
Type- 2 Diabetes, Thyroid Dysfunction, Hypothyroidism
[1]
Wild. Estimates for the year 2000 and projections for 2030. World Health. 2004;27(5):1047–53.
[2]
Kalra S. Recent advances in endocrionology,Thyroid disorders and diabetes. 2014;64(8):966–8.
[3]
Hage M, Zantout MS, Azar ST. Thyroid disorders and diabetes mellitus. J Thyroid Res. 2011;2011:439463.
[4]
SHORT REPORTS Screening for thyroid dysfunction in diabetics. 1979;(JUNE):1979.
[5]
Hyperthyroidism For personal use . Only reproduce with permission from The Lancet . 2003;362:2003.
[6]
Johnson JL. Diabetes Control in Thyroid Disease. Diabetes Spectr. 2006;19(3):148–53.
[7]
Artero P C, C C, S G. Fish Oil Metabolites: Translating Promising Findings from Bench to bedside to Reduce Cardiovascular Disease. J Glycomics Lipidomics. 2012;02(1):1–4.
[8]
Papazafiropoulou A, Sotiropoulos A, Kokolaki A, Kardara M, Stamataki P, Pappas S. Prevalence of thyroid dysfunction among greek type 2 diabetic patients attending an outpatient clinic. J Clin Med Res. 2010;2(2):75–8.
[9]
Ghazali SM, Abbiyesuku FM. Thyroid dysfunction in type 2 diabetics seen at the University College Hospital , Ibadan , Nigeria. 2010;25(December):173–9.
[10]
Radaideh A-RM, Nusier MK, Amari FL, Bateiha AE, El-Khateeb MS, Naser AS, et al. Thyroid dysfunction in patients with type 2 diabetes mellitus in Jordan. Saudi Med J. Saudi Arabia; 2004 Aug;25(8):1046–50.
[11]
Akbar DH, Ahmed MM, Al-Mughales J. Thyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics. Acta Diabetol. Germany; 2006 May;43(1):14–8.
[12]
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. UNITED STATES; 2000 Feb;160(4):526–34.
[13]
Palma CCSSV, Pavesi M, Nogueira VG, Clemente ELS, Vasconcellos MDFBMP, Pereira LC, et al. Prevalence of thyroid dysfunction in patients with diabetes mellitus. Diabetol Metab Syndr [Internet]. 2013;5:58. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3852595&tool=pmcentrez&rendertype=abstract
[14]
Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med. ENGLAND; 1995 Jul;12(7):622–7.
[15]
Kumar A, Lalith R. ahoo . co . in tes , Hypothy yroidism , H Hyperthyroid dism. :93–100.
[16]
Ghazali SM, Abbiyesuku FM. Thyroid dysfunction in type 2 diabetics seen at the University College Hospital, Ibadan, Nigeria. Niger J Physiol Sci. Nigeria; 2010;25(2):173–9.
[17]
Umpierrez GE, Latif K a., Murphy MB, Lambeth HC, Stentz F, Bush a., et al. Thyroid Dysfunction in Patients With Type 1 Diabetes: A longitudinal study . Diabetes Care. 2003;26(4):1181–5.
[18]
Kharb S. Dual energy X ¬ ray absorptiometry : Pitfalls in measurement and interpretation of bone mineral density. 2013;17(Suppl 2):203–10.
[19]
Chen H-S, Wu T-EJ, Jap T-S, Lu R-A, Wang M-L, Chen R-L, et al. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients. Diabet Med. England; 2007 Dec;24(12):1336–44.
[20]
Vikhe VB, Kanitkar SA, Tamakuwala KK, Gaikwad AN, Kalyan M, Agarwal RR. Thyroid dysfunction in patinets with type 2 dibates mellitus at tertiary care centre. Natl J Med Res. 2013;3(4):2–5.
